To invest in a concentrated portfolio of approximately 30-80 stocks of companies incorporated in emerging markets, and whose securities are listed or traded on a recognised market.
Name | % Net Assets |
---|---|
Petrobras | 5.2% |
Teva Pharmaceuticals | 4.7% |
China Mobile | 4.1% |
Vale On ADR | 4.0% |
Ind. & Comm. Bank of China | 3.9% |
Sasol | 3.7% |
Reliance Industries | 3.7% |
OAO Gazprom | 3.5% |
China Life Insurance | 3.0% |
Samsung Electronics | 2.9% |
Key | % Net Assets |
---|---|
Petrobras | 5.2% |
Teva Pharmaceuticals | 4.7% |
China Mobile | 4.1% |
Vale On ADR | 4.0% |
Other | 82% |
Date | 04-Jun-2015 |
---|---|
NAV | 115.12p |
Currency | GBP |
Change | -1.39p |
% | -1.30% |
YTD change | 115.12p |
YTD % | n/a |
Fund Inception | 11/02/2009 |
---|---|
Fund Manager | n/a |
TER | 1.07 (15-Jan-2014) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research